Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigeki Umemura

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Japanese Journal of Clinical Oncology|February 12, 2015
Genomic profiling of small-cell lung cancer: the era of targeted therapiesShigeki Umemura, Katsuya Tsuchihara, Koichi Goto
World Journal of Gastroenterology|September 23, 2008
Asymptomatic colonic metastases from primary squamous cell carcinoma of the lung with a positive fecal occult blood testShoji Hirasaki, Seiyuu Suzuki, Shigeki Umemura, et al.
Anticancer Research|June 29, 2007
Role of early serial change in serum carcinoembryonic antigen levels as a predictive marker for radiological response to gefitinib in Japanese patients with non-small cell lung cancerKatsuyuki Hotta, Katsuyuki Kiura, Masahiro Tabata, et al.
Anticancer Research|March 14, 2013
Safety and efficacy of platinum agents plus etoposide for patients with small cell lung cancer with interstitial lung diseaseTatsuya Yoshida, Kiyotaka Yoh, Koichi Goto, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
Switch maintenance chemotherapy using S-1 with or without bevacizumab in patients with advanced non-small cell lung cancer: a phase II studySeiji Niho, Yuichiro Ohe, Hironobu Ohmatsu, et al.
Journal of Cancer Research and Clinical Oncology|February 22, 2017
Impact of denosumab use on the survival of untreated non-squamous non-small cell lung cancer patients with bone metastasesHibiki Udagawa, Seiji Niho, Keisuke Kirita, et al.
Japanese Journal of Clinical Oncology|April 4, 2015
Docetaxel for platinum-refractory advanced thymic carcinomaNaohiro Watanabe, Shigeki Umemura, Seiji Niho, et al.
World Journal of Gastrointestinal Oncology|November 24, 2011
Variant angina pectoris associated with FOLFOX4 therapyHiromichi Yamane, Minoru Matsubara, Shigeki Umemura, et al.
Japanese Journal of Clinical Oncology|July 25, 2014
Low-dose irinotecan as a second-line chemotherapy for recurrent small cell lung cancerMasahiro Morise, Seiji Niho, Shigeki Umemura, et al.
Clinical Lung Cancer|March 6, 2016
Clinical Impact of Gastric Acid-Suppressing Medication Use on the Efficacy of Erlotinib and Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer Harboring EGFR MutationsYoshitaka Zenke, Kiyotaka Yoh, Shingo Matsumoto, et al.
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Japanese Journal of Clinical Oncology|February 12, 2015
Genomic profiling of small-cell lung cancer: the era of targeted therapiesShigeki Umemura, Katsuya Tsuchihara, Koichi Goto
World Journal of Gastroenterology|September 23, 2008
Asymptomatic colonic metastases from primary squamous cell carcinoma of the lung with a positive fecal occult blood testShoji Hirasaki, Seiyuu Suzuki, Shigeki Umemura, et al.
Anticancer Research|June 29, 2007
Role of early serial change in serum carcinoembryonic antigen levels as a predictive marker for radiological response to gefitinib in Japanese patients with non-small cell lung cancerKatsuyuki Hotta, Katsuyuki Kiura, Masahiro Tabata, et al.
Anticancer Research|March 14, 2013
Safety and efficacy of platinum agents plus etoposide for patients with small cell lung cancer with interstitial lung diseaseTatsuya Yoshida, Kiyotaka Yoh, Koichi Goto, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
Switch maintenance chemotherapy using S-1 with or without bevacizumab in patients with advanced non-small cell lung cancer: a phase II studySeiji Niho, Yuichiro Ohe, Hironobu Ohmatsu, et al.
Journal of Cancer Research and Clinical Oncology|February 22, 2017
Impact of denosumab use on the survival of untreated non-squamous non-small cell lung cancer patients with bone metastasesHibiki Udagawa, Seiji Niho, Keisuke Kirita, et al.
Japanese Journal of Clinical Oncology|April 4, 2015
Docetaxel for platinum-refractory advanced thymic carcinomaNaohiro Watanabe, Shigeki Umemura, Seiji Niho, et al.
World Journal of Gastrointestinal Oncology|November 24, 2011
Variant angina pectoris associated with FOLFOX4 therapyHiromichi Yamane, Minoru Matsubara, Shigeki Umemura, et al.
Japanese Journal of Clinical Oncology|July 25, 2014
Low-dose irinotecan as a second-line chemotherapy for recurrent small cell lung cancerMasahiro Morise, Seiji Niho, Shigeki Umemura, et al.
Clinical Lung Cancer|March 6, 2016
Clinical Impact of Gastric Acid-Suppressing Medication Use on the Efficacy of Erlotinib and Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer Harboring EGFR MutationsYoshitaka Zenke, Kiyotaka Yoh, Shingo Matsumoto, et al.
Pageof 11